Incidence and risk factors for cervical lesions in patients with rheumatoid arthritis under the current pharmacologic treatment paradigm

References

• Pellicci PM, Ranawat CS, Tsairis P, Bryan WJ. A prospective study of the progression of rheumatoid arthritis of the cervical spine. J Bone Joint Surg Am. 1981;63:342–50.
   PubMed Web of Science ®Google Scholar
• Bouchaud-Chabot A, Lioté F. Cervical spine involvement in rheumatoid arthritis: a review. Joint Bone Spine. 2002;69:141–54.
   PubMed Web of Science ®Google Scholar
• Choi D, Casey AT, Crockard HA. Neck problems in rheumatoid arthritis-changing disease patterns, surgical treatments and patients' expectations. Rheumatology (Oxford). 2006;45:1183–4.
   PubMed Web of Science ®Google Scholar
• Sunahara N, Matsunaga S, Mori T, Ijiri K, Sakou T. Clinical course of conservatively managed rheumatoid arthritis patients with myelopathy. Spine. 1997;22:2603–7.
   PubMed Web of Science ®Google Scholar
• Yamanaka H, Sugiyama N, Inoue E, Taniguchi A, Momohara S. Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I). Mod Rheumatol. 2014;24:33–40.
   PubMed Web of Science ®Google Scholar
• Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med. 2000;343:1594–602.
   PubMed Web of Science ®Google Scholar
• St Clair EW, van der Heijde DM, Smolen JS, Maini RN, Balthon JM, Emery P, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum. 2004;50:3432–43.
   PubMed Web of Science ®Google Scholar
• Kaito T, Hosono N, Ohshima S, Ohwaki H, Takenaka S, Fujiwara H, et al. Effect of biological agents on cervical spine lesions in rheumatoid arthritis. Spine. 2012;37:1742–46.
   PubMed Web of Science ®Google Scholar
• Kaito T, Ohshima S, Fujiwara H, Makino T, Yonenobu K. Predictors for the progression of cervical lesion in rheumatoid arthritis under the treatment of biological agents. Spine. 2013;38:2258–63.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Landewé R, Breedveld FC, Bush M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73:492–509.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Steinbrocke O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc. 1949;140:659–62.
   PubMed Web of Science ®Google Scholar
• Ranawat CS, O’Leary P, Pellicci P, Tsairis P, Marchisello P, Dorr L. Cervical spine fusion in rheumatoid arthritis. J Bone Joint Surg Am. 1979;61:1003–10.
   PubMed Web of Science ®Google Scholar
• Oda T, Fujiwara K, Yonenobu K, Azuma B, Ochi T. Natural course of cervical spine lesions in rheumatoid arthritis. Spine. 1995;20:1128–35.
   PubMed Web of Science ®Google Scholar
• Fujiwara K, Owaki H, Fujimoto M, Yonenobu K, Ochi T. A long-term follow-up study of cervical lesions in rheumatoid arthritis. J Spinal Disord. 2000;13:519–26.
   PubMedGoogle Scholar
• Yurube T, Sumi M, Nishida K, Takabatake M, Kohyama K, Matsubara T, et al. Progression of cervical spine instabilities in rheumatoid arthritis: a prospective cohort study of outpatients over 5 years. Spine. 2011;36:647–53.
   PubMed Web of Science ®Google Scholar
• Zhang T, Pope J. Cervical spine involvement in rheumatoid arthritis over time: results from a meta-analysis. Arthritis Res Ther. 2015;17:148.
   PubMed Web of Science ®Google Scholar
• Chen TS, Crues 3rd JV, Ali MM, Troum OM. Magnetic resonance imaging is more sensitive than radiographs in detecting change in size of erosions in rheumatoid arthritis. J Rheumatol. 2006;33:1957–67.
   PubMed Web of Science ®Google Scholar
• Rastogi A, Algulin J, Mangat P, Lim AK, Satchithananda K, Hajnal JV, et al. Early metacarpal bone mineral density loss using digital X-ray radiogrammetry and 3-tesla wrist MRI in established rheumatoid arthritis: a longitudinal one-year observational study. Arthritis. 2015;2015:852989. doi: 10.1155/2015/852989.
   PubMed Web of Science ®Google Scholar
• Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol. 1989;16:585–91.
   PubMed Web of Science ®Google Scholar
• Imagama S, Oishi Y, Miura Y, Kanayama Y, Ito Z, Wakao N, et al. Predictors of aggravation of cervical spine instability in rheumatoid arthritis patients: the large joint index. J Orthop Sci. 2010;15:540–6.
   PubMed Web of Science ®Google Scholar
• Kanayama Y, Kojima T, Hirano Y, Shioura T, Hayashi M, Funahashi K, et al. Radiographic progression of cervical lesions in patients with rheumatoid arthritis receiving infliximab treatment. Mod Rheumatol. 2010;20:273–9.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Suzuki A, Koike T, Yamada K, Yasuda H, Tada M, et al. Current prevalence and characteristics of cervical spine instability in patients with rheumatoid arthritis in the era of biologics. Mod Rheumatol. 2014;24:904–9.
   PubMed Web of Science ®Google Scholar
• Landewé R, van der Heijde D, Klareskog L, van Vollenhoven R, Fatenejad S. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Arthritis Rheum. 2006;54:3119–25.
   PubMed Web of Science ®Google Scholar